GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (STU:AGT) » Definitions » Short Interest

AptarGroup (STU:AGT) Short Interest


View and export this data going back to 2013. Start your Free Trial

What is AptarGroup Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of AptarGroup's Short Interest

For the Medical Instruments & Supplies subindustry, AptarGroup's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AptarGroup's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Short Interest distribution charts can be found below:

* The bar in red indicates where AptarGroup's Short Interest falls into.


AptarGroup (STU:AGT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (STU:AGT) » Definitions » Short Interest
Comparable Companies
TFX RGEN XRAY STVN MMSI HAE NVST AZTA ICUI HOLX ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN
Traded in Other Exchanges
ATR:USA AGT:Germany
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Website
https://www.aptar.com
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.

AptarGroup (STU:AGT) Headlines